Intrinsic Value

Esperion Therapeutics, Inc. (ESPR)


-0.06 (-6.26%)
Enterprise Value -
Net Debt 136.17
Equity Value -
Shares Outstanding 66.41
Equity Value Per Share -

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt